| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/TP.0B013E31819F12BE |
| P698 | PubMed publication ID | 19384172 |
| P50 | author | Matthew D Griffin | Q73267381 |
| Latonya J Hickson | Q83699620 | ||
| P2093 | author name string | Mark D Stegall | |
| Michael B Ishitani | |||
| Dawn S Milliner | |||
| James M Gloor | |||
| Fernando G Cosio | |||
| Timothy S Larson | |||
| Corey W Iqbal | |||
| Hatem Amer | |||
| Manish Gera | |||
| Therese B Moore | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney transplantation | Q740909 |
| focal segmental glomerulosclerosis | Q1435223 | ||
| P304 | page(s) | 1232-1239 | |
| P577 | publication date | 2009-04-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence | |
| P478 | volume | 87 |
| Q58747177 | A large, international study on post-transplant glomerular diseases: the TANGO project |
| Q34596244 | A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation |
| Q35986440 | Acute renal allograft dysfunction due to cecal volvulus: a case report. |
| Q89641949 | Adrenocorticotrophic Hormone-Induced Remission of Pediatric Post-transplantation Recurrent Focal Segmental Glomerulosclerosis |
| Q82978780 | Case report: successful treatment of recurrent focal segmental glomerulosclerosis with a novel rituximab regimen |
| Q39009557 | Chronic allograft injury: Mechanisms and potential treatment targets |
| Q34660324 | Circulating Permeability Factors in Idiopathic Nephrotic Syndrome and Focal Segmental Glomerulosclerosis |
| Q33872298 | Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis |
| Q54985317 | Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults. |
| Q90565319 | Combination of High-Dose Intravenous Cyclosporine and Plasma Exchange Treatment Is Effective in Post-Transplant Recurrent Focal Segmental Glomerulosclerosis: Results of Case Series |
| Q38447182 | Combined use of rituximab and plasmapheresis pre-transplant increases post-transplant infections in renal transplant recipients with basiliximab induction therapy |
| Q47653949 | Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances |
| Q92405079 | Disease Recurrence-The Sword of Damocles in Kidney Transplantation for Primary Focal Segmental Glomerulosclerosis |
| Q42146267 | Early focal segmental glomerulosclerosis as a cause of renal allograft primary nonfunction. |
| Q33912900 | Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients |
| Q26752840 | FSGS Recurrence in Adults after Renal Transplantation |
| Q41671163 | Fatal late-onset Pneumocystis pneumonia after rituximab: administration for posttransplantation recurrence of focal segmental glomerulosclerosis--case report |
| Q37928188 | Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients |
| Q38192853 | Focal segmental glomerulosclerosis: towards a better understanding for the practicing nephrologist |
| Q90458584 | Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis |
| Q33660667 | Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence |
| Q92120493 | Long-Term Follow-up Results of Renal Transplantation in Pediatric Patients With Focal Segmental Glomerulosclerosis: A Single-Center Experience |
| Q46803769 | Long-Term Outcome of Kidney Transplantation in Recipients with Focal Segmental Glomerulosclerosis |
| Q38243597 | Management of proteinuria in the transplanted patient |
| Q35932485 | National trends over 25 years in pediatric kidney transplant outcomes |
| Q99584633 | Nonrecurrent Early Post-Transplantation Focal Segmental Glomerulosclerosis |
| Q37658483 | Novel biomarkers in glomerular disease |
| Q39331611 | Optimal management of primary focal segmental glomerulosclerosis in adults |
| Q34645201 | Pathophysiology and treatment of focal segmental glomerulosclerosis: the role of animal models |
| Q26772265 | Plasma Exchange for the Recurrence of Primary Focal Segmental Glomerulosclerosis in Adult Renal Transplant Recipients: A Meta-Analysis |
| Q86215247 | Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis |
| Q34363025 | Plasmapheresis and immunoadsorption for treatment and prophylaxis of recurrent focal segmental glomerulosclerosis in adult recipients of deceased donor renal grafts |
| Q33632316 | Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy |
| Q54939984 | Preoperative Low-Density Lipoprotein Apheresis for Preventing Recurrence of Focal Segmental Glomerulosclerosis after Kidney Transplantation. |
| Q40622553 | Primary and Recurrent Focal Segmental Glomerulosclerosis Closely Link to Serum Soluble Urokinase-type Plasminogen Activator Receptor Levels |
| Q38445275 | Primary disease recurrence—effects on paediatric renal transplantation outcomes |
| Q64929779 | Prospects of genetic testing for steroid-resistant nephrotic syndrome in Nigerian children: a narrative review of challenges and opportunities. |
| Q36572659 | Recent progress in the pathophysiology and treatment of FSGS recurrence |
| Q26746985 | Recurrence and Treatment after Renal Transplantation in Children with FSGS |
| Q37781991 | Recurrence of focal segmental glomerulosclerosis after kidney transplantation: strategies and outcome |
| Q38209829 | Recurrence of idiopathic focal segmental glomerulosclerosis after kidney transplantation: experience of a Korean tertiary center |
| Q47193282 | Recurrence of primary glomerulonephritis: Review of the current evidence |
| Q93047764 | Recurrent and de novo Glomerulonephritis After Kidney Transplantation |
| Q38359297 | Recurrent focal segmental glomerulosclerosis after kidney transplantation |
| Q47631109 | Renal transplant outcomes in primary FSGS compared with other recipients and risk factors for recurrence: A national review of the Irish Transplant Registry. |
| Q47392476 | Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation. |
| Q37989298 | Rituximab in immunologic glomerular diseases |
| Q36522082 | Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis |
| Q37218346 | Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome |
| Q30541740 | Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis |
| Q39557822 | Role of race in kidney transplant outcomes in children with focal segmental glomerulosclerosis |
| Q51033762 | Selection of Patients for Initial Clinical Trials of Solid Organ Xenotransplantation. |
| Q92418202 | Successful Treatment of Recurrent Focal Segmental Glomerulosclerosis After Transplantation in Children: A Single-Center Experience |
| Q37969115 | The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review |
| Q30454792 | Therapeutic apheresis rescue mission: recurrent focal segmental glomerulosclerosis in renal allografts |
| Q38118112 | Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013. |
| Q34961453 | Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab. |
| Q37970443 | Update on the role of rituximab in kidney diseases and transplant |
| Q26751470 | Update on the treatment of focal segmental glomerulosclerosis in renal transplantation |
| Q33783271 | Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis |
| Q33993597 | Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates |
| Q39229298 | What are we missing in the clinical trials of focal segmental glomerulosclerosis? |
Search more.